Platelet parameters | Control range | Patient | Units |
---|---|---|---|
Platelet count | 229 (219–376)* | 40 | ×109/L |
FSC (platelet size) | Â | ||
At rest | 107 (81–121) | 131 | % |
Activated | 69 (54–79) | 100 | % |
FSC ratio at rest / after activation | 1.53 (1.37–2.09) | 1.31 | Ratio |
SSC (platelet granularity) | Â | ||
At rest | 84.6 (70-93.4) | 118 | % |
Activated | 84.2 (57.5–66.9) | 121 | % |
SSC ratio at rest / after activation | 1.19 (1.11–1.58) | 0.98 | Ratio |
GP Ib (CD42b antigen) | Â | ||
At rest | 99 (68–118) | 107 | % |
Activated | 57 (46–71) | 79 | % |
CD42b ratio at rest/after activation | 1.71 (1.43–2.39) | 1.35 | Ratio |
GP IIIa (CD61 antigen) | Â | ||
At rest | 98 (91–113) | 104 | % |
Activated | 261 (211–352) | 352 | % |
CD61 ratio after activation / at rest | 2.58 (2.28–3.45) | 3.38 | Ratio |
PAC-1 binding (activated GP IIb/IIIa) | Â | ||
At rest | 3.31 (3.02–4.1) | 6.1 | % |
Activated | 116 (76–165) | 45 | % |
PAC-1 ratio after activation / at rest | 36 (21–48) | 7.38 | Ratio |
Fluorescence of loaded mepacrine in dense granules | Â | ||
At rest | 85 (73–118) | 156 | % |
Activated | 22 (19–35) | 57 | % |
Dense granules release Index at rest/after activation | 4.1 (2.2–4.8) | 2.7 | Ratio |
P-selectin (CD62p antigen) | Â | ||
At rest | 2.35 (2.1-4) | 2.8 | % |
Activated | 93 (78–114) | 99 | % |
Release index of α-granules (by CD62p) after activation / at rest | 41 (20-47.5) | 35.4 | Ratio |
Fraction of procoagulant PS + platelets (by Annexin V) |  | ||
At rest | 0.3 (0.05–0.7) | 0.32 | % |
Activated | 19 (6.2–37.1) | 14.0 | % |